Published in Nephrol Dial Transplant on November 01, 1998
Iron therapy for renal anemia: how much needed, how much harmful? Pediatr Nephrol (2007) 0.93
Does ascorbic acid supplementation affect iron bioavailability in rats fed micronized dispersible ferric pyrophosphate fortified fruit juice? Eur J Nutr (2008) 0.79
Effect of short-term intravenous ascorbic acid on reducing ferritin in hemodialysis patients. Indian J Nephrol (2012) 0.79
Comparative study of intravenous iron versus intravenous ascorbic Acid for treatment of functional iron deficiency in patients under hemodialysis: a randomized clinical trial. Nephrourol Mon (2013) 0.77
The effect of intravenous ascorbic acid in hemodialysis patients with normoferritinemic anemia. Kidney Res Clin Pract (2012) 0.77
Vitamin C and functional iron deficiency anemia in hemodialysis. Kidney Res Clin Pract (2012) 0.75
Tubular epithelial-myofibroblast transdifferentiation in progressive tubulointerstitial fibrosis in 5/6 nephrectomized rats. Kidney Int (1998) 2.35
Uremic pruritus: roles of parathyroid hormone and substance P. J Am Acad Dermatol (1997) 1.61
Anatomical variation of the internal jugular vein and its impact on temporary haemodialysis vascular access: an ultrasonographic survey in uraemic patients. Nephrol Dial Transplant (1998) 1.55
Effect of vitamin E-bonded membrane on the 8-hydroxy 2'-deoxyguanosine level in leukocyte DNA of hemodialysis patients. Kidney Int (2000) 1.25
Glomerular epithelial-myofibroblast transdifferentiation in the evolution of glomerular crescent formation. Nephrol Dial Transplant (1999) 1.10
Erythropoietin hyporesponsiveness: from iron deficiency to iron overload. Kidney Int Suppl (1999) 0.96
Activation of Kupffer cells and caspase-3 involved in rat hepatocyte apoptosis induced by endotoxin. J Hepatol (1999) 0.91
Peritoneal dialysis solution induces apoptosis of mesothelial cells. Kidney Int (1997) 0.91
Spurious hyperchloremia and decreased anion gap in a patient with dextromethorphan bromide. Am J Nephrol (1992) 0.91
Serial changes of interleukin-6 and interleukin-8 levels in drain dialysate of uremic patients with continuous ambulatory peritoneal dialysis during peritonitis. Nephron (1993) 0.89
8-hydroxy-2'-deoxyguanosine of leukocyte DNA as a marker of oxidative stress in chronic hemodialysis patients. Am J Kidney Dis (2000) 0.88
Ultrasound-guided cannulation of the internal jugular vein for dialysis vascular access in uremic patients. Nephron (1998) 0.85
Endothelin A-receptor blockade worsens endotoxin-induced hepatic microcirculatory changes and necrosis. Gastroenterology (1998) 0.85
Persistent transforming growth factor-beta 1 expression may predict peritoneal fibrosis in CAPD patients with frequent peritonitis occurrence. Am J Nephrol (1998) 0.85
Reduction of serum calcium by sodium sulfonated polystyrene resin. J Formos Med Assoc (1990) 0.85
Intravenous ascorbic acid as an adjuvant therapy for recombinant erythropoietin in hemodialysis patients with hyperferritinemia. Kidney Int (1999) 0.84
Chorea induced by thiamine deficiency in hemodialysis patients. Am J Kidney Dis (2001) 0.83
Resistance to erythropoietin: immunohemolytic anemia induced by residual formaldehyde in dialyzers. Am J Kidney Dis (1993) 0.83
PCR diagnosis on formalin-fixed, paraffin-embedded tissues with acid-fast stain and culture negativity in chronic dialysis patients of cervico-mediastinal tuberculous lymphadenitis. Nephrol Dial Transplant (1998) 0.83
Brachial plexus compression due to subclavian pseudoaneurysm from cannulation of jugular vein hemodialysis catheter. Am J Kidney Dis (1998) 0.83
Thiamine deficiency and unexplained encephalopathy in hemodialysis and peritoneal dialysis patients. Am J Kidney Dis (2001) 0.83
Spiral computed tomographic angiography--a new technique for evaluation of vascular access in hemodialysis patients. Am J Nephrol (1998) 0.81
Comparative effect of oral or intravenous calcitriol on secondary hyperparathyroidism in chronic hemodialysis patients. Miner Electrolyte Metab (1994) 0.81
Iron metabolism indices for early prediction of the response and resistance to erythropoietin therapy in maintenance hemodialysis patients. Am J Nephrol (1995) 0.81
Increased excretion of tumor necrosis factor alpha and interleukin 1 beta in urine from patients with IgA nephropathy and Schönlein-Henoch purpura. Nephron (1996) 0.81
Hemodialysis-related pruritus: a double-blind, placebo-controlled, crossover study of capsaicin 0.025% cream. Nephron (1996) 0.81
The association of aldosterone-producing adrenal adenoma in a patient with autosomal dominant polycystic kidney disease. Am J Kidney Dis (1994) 0.81
Serial peritoneal macrophage function studies in new and established continuous ambulatory peritoneal dialysis patients. Am J Nephrol (1990) 0.79
Anti-Nform antibody in hemodialysis patients. Am J Nephrol (1995) 0.79
Persistent transforming growth factor beta 1 expression may predict peritoneal fibrosis in CAPD patients with frequent peritonitis occurrence. Adv Perit Dial (1997) 0.79
An occult cause of arteriovenous access failure: central vein stenosis from permanent pacemaker wire. Report of three cases and review of the literature. Am J Nephrol (2001) 0.79
Low molecular weight heparin in diabetic and nondiabetic hypercholesterolemic patients receiving long-term hemodialysis. J Formos Med Assoc (1998) 0.78
Resistance to recombinant human erythropoietin treatment in thalassaemic patients on chronic haemodialysis: a real clinical entity? Nephrol Dial Transplant (1996) 0.78
Enhancement of ionized calcium and 1,25-dihydroxycholecalciferol loss from peritoneal fluid during peritonitis in patients treated with continuous ambulatory peritoneal dialysis. Nephron (1991) 0.78
Intravenous infusion or nebulization of salbutamol for treatment of hyperkalemia in patients with chronic renal failure. Zhonghua Yi Xue Za Zhi (Taipei) (1994) 0.78
Erythropoietin and iron: the role of ascorbic acid. Nephrol Dial Transplant (2001) 0.78
Pancreatic enzymes in uremic patients with or without dialysis. Clin Biochem (1988) 0.78
Effects of low-protein diet on experimental diabetic nephropathy in the rat. J Lab Clin Med (1985) 0.78
Renal function in gout patients. Am J Nephrol (1995) 0.77
Hypokalemic effects of intravenous infusion or nebulization of salbutamol in patients with chronic renal failure: comparative study. Am J Kidney Dis (1994) 0.77
Improvement of rat liver graft function by insulin administration to donor. Gastroenterology (1996) 0.76
Hyporesponsiveness to erythropoietin. Perit Dial Int (1997) 0.75
[Catheter-related problems in continuous ambulatory peritoneal dialysis]. Taiwan Yi Xue Hui Za Zhi (1988) 0.75
Diabetes insipidus as an early sign of pineal tumor. Am J Nephrol (1995) 0.75
Dialyzer reuse: interaction between dialyzer membrane, disinfectant (formalin), and blood during dialyzer reprocessing. Artif Organs (1996) 0.75
Recombinant human erythropoietin resistance in iron-replete hemodialysis patients: role of aluminum toxicity. Am J Nephrol (1998) 0.75
Mathematical approach for estimating iron needs in hemodialysis patients on erythropoietin therapy. Am J Nephrol (1997) 0.75
Antibodies to hepatitis C virus in uremic patients on continuous ambulatory peritoneal dialysis. J Med Virol (1991) 0.75
Beta-adrenergic-mediated extrarenal potassium disposal in patients with end-stage renal disease: effect of propranolol. Miner Electrolyte Metab (1986) 0.75
Vagus-pituitary pressor response after adrenal extirpation. Chin Med J (Engl) (1978) 0.75
Serum transferrin receptor concentration is not indicative of erythropoietic activity in chronic hemodialysis patients with poor response to recombinant human erythropoietin. Zhonghua Yi Xue Za Zhi (Taipei) (1998) 0.75
Absence of modulating effects of cytokines on antioxidant enzymes in peritoneal mesothelial cells. Perit Dial Int (1997) 0.75
Clinical spectrum of rapidly progressive glomerulonephritis. Taiwan Yi Xue Hui Za Zhi (1984) 0.75
Effect of long-term therapy with captopril on proteinuria and renal function in patients with non-insulin-dependent diabetes and with non-diabetic renal diseases. Nephron (1995) 0.75
Optimal time to restart conventional CAPD after laparoscopic revision of CAPD catheters. Perit Dial Int (1997) 0.75
Decreased size of peritoneal macrophage during peritonitis in continuous ambulatory peritoneal dialysis patients. Am J Nephrol (1991) 0.75
Recombinant human erythropoietin for anaemia in nephrotic syndrome with thalassemia. Clin Nephrol (1997) 0.75
Focal segmental glomerulosclerosis after poststreptococcal glomerulonephritis in the elderly: a case report. Zhonghua Yi Xue Za Zhi (Taipei) (1998) 0.75
The removal index for evaluation of dialysis. Perit Dial Int (1997) 0.75
A malnourished haemodialysis patient-a diagnostic surprise. Nephrol Dial Transplant (2000) 0.75
Neurochemical evaluation of chlordecone toxicity in the mouse. J Toxicol Environ Health (1982) 0.75
Propranolol intoxication: three cases' experiences. Vet Hum Toxicol (1985) 0.75
The need for second-generation antihepatitis C virus testing in uremic patients on continuous ambulatory peritoneal dialysis. Perit Dial Int (1993) 0.75
Home treatment of uremia with gastrointestinal dialysis. Clin Nephrol (1978) 0.75
Effect of intravenous calcitriol on secondary hyperparathyroidism in chronic hemodialysis patients. Zhonghua Yi Xue Za Zhi (Taipei) (1994) 0.75
Dialysis-related amyloidosis and acquired renal cystic disease with renal cell carcinoma in uremia. Nephron (1994) 0.75
Significance of nitrogen removal mass in uremic patients on different modalities of dialysis therapy. J Formos Med Assoc (2000) 0.75
Serial cell-mediated immunological changes in terminal uremic patients on continuous ambulatory peritoneal dialysis therapy. Am J Nephrol (1988) 0.75
Renovascular hypertension after laparoscopic adrenalectomy in a patient with adrenal adenoma. Nephron (1996) 0.75
Studies on the tissue specificity of 125I-alpha-bungarotoxin. Taiwan Yi Xue Hui Za Zhi (1976) 0.75
Resistance to recombinant erythropoietin in a hemodialysis patient with heterozygous hemoglobinopathy J-Meinung. Am J Kidney Dis (1997) 0.75
Interzeta-globin gene hypervariable regions in Chinese: application to genetic diagnosis of adult polycystic kidney disease. Hum Hered (1989) 0.75
Adsorption and thermal reactions of alkanethiols on pt(111): Dependence on the length of the alkyl chain. J Phys Chem B (2005) 0.75
The weekly removal mass of urea nitrogen in CAPD and conventional HD. Perit Dial Int (1994) 0.75
[Autosomal dominant polycystic kidney disease clinical analysis in VGH--Taipei]. Zhonghua Yi Xue Za Zhi (Taipei) (1990) 0.75
RBC morphology in differential diagnosis of hematuria. Taiwan Yi Xue Hui Za Zhi (1986) 0.75
[The long-term effects of cyclosporine on cultured rat mesangial cell]. Zhonghua Yi Xue Za Zhi (Taipei) (1992) 0.75
Improvement of nutritional status in patients receiving maintenance hemodialysis after correction of renal anemia with recombinant human erythropoietin. Nephron (1998) 0.75
Serial peritoneal macrophage function studies in CAPD patients with peritonitis. Adv Perit Dial (1990) 0.75
Chlorobutanol, a preservative of desmopressin, inhibits human platelet aggregation and release in vitro. Thromb Haemost (1990) 0.75
Internal jugular vein haemodialysis catheter-induced right atrium endocarditis--case report and review of the literature. Scand J Urol Nephrol (1998) 0.75
Uraemic pericarditis: a reversible inflammatory state of resistance to recombinant human erythropoietin in haemodialysis patients. Nephrol Dial Transplant (1997) 0.75
Continuous ambulatory peritoneal dialysis for the end stage renal disease patients. Taiwan Yi Xue Hui Za Zhi (1986) 0.75